2016
DOI: 10.1038/nrd.2016.31
|View full text |Cite
|
Sign up to set email alerts
|

Convertible visceral fat as a therapeutic target to curb obesity

Abstract: New therapeutic and preventative strategies are needed to address the growing obesity epidemic. In animal models, brown adipose tissue activation and the associated heat produced contribute to countering obesity and the accompanying metabolic abnormalities. Adult humans also have functional brown fat. Here, we present and discuss the concepts of murine and human white adipose tissue plasticity and the transdifferentiation of white adipocytes into brown adipocytes. Human visceral adipocytes - which are crucial … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
245
0
3

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 205 publications
(253 citation statements)
references
References 243 publications
5
245
0
3
Order By: Relevance
“…The use of anti-obesity agents, consisting mainly of those that reduce appetite or inhibit nutrient absorption, is compromised by issues of poor efficacy and unacceptable side effects 34 . Thus, the therapeutic armamentarium for obesity currently pales in comparison with that of other public health hazards of similar or lesser magnitudes, such as hypertension, diabetes or osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…The use of anti-obesity agents, consisting mainly of those that reduce appetite or inhibit nutrient absorption, is compromised by issues of poor efficacy and unacceptable side effects 34 . Thus, the therapeutic armamentarium for obesity currently pales in comparison with that of other public health hazards of similar or lesser magnitudes, such as hypertension, diabetes or osteoporosis.…”
Section: Discussionmentioning
confidence: 99%
“…However, cannabinoid receptor type 2 receptor polymorphisms are associated with obesity and the cannabinoid receptor type 2 agonist JWH-133 enhanced adipocyte UCP-1 expression (consistent with a browning effect) and hindered IL-6 release 56 . In addition to these potential candidates for drug development, several other classes of molecules are in clinical trials for obesity modulate brown fat and energy intake and expenditure and have been reviewed 57 .…”
Section: Macrophage Functions In Lean Tissuementioning
confidence: 99%
“…1). BAT activity can be increased upon cold exposure and noradrenergic stimulation, and also pharmacologically (Giordano et al, 2016) and by fasting (Migliorini et al, 1997). In humans, active BAT was believed to be only present in the neck and shoulder of newborns and small children, where its function was attributed to be maintenance of body temperature upon cold exposure to compensate for the lack of shivering-thermogenesis (Lean, 1989).…”
Section: Adipose Tissue Depotsmentioning
confidence: 99%